constant diarrhea on glp 1 and glp1 use. This is a common side effect typically seem towards the beginning of your GLP1 journey. However, we can see it resurface with dose increment. Reasons for diarrhea Long-Term Effects Of GLP-1 Medications:

11,2325 EMPA-REG OUTCOME was a randomized, double-blind, placebo-controlled trial involving 7,020 patients with T2D and established cardiovascular disease (CVD)

They work through different mechanisms and are metabolised via distinct pathways, making them generally safe to take together under medical supervision

Science-Backed 5-Piece GLP-1 Metabolic Support Stack for Satiety, Appetite Control & Healthy Post-Meal Energy

[DOI] [PubMed] [Google Scholar] 81.McIntyre R.S., Mansur R.B., Rosenblat J.D., Kwan A.T.H

Public Health Recommendations The CPHA article outlines three recommendations for the public health sector: Addressing industry influence and the commercial determinants of health, including engagement in policy reform around drug pricing, regulation, and access [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective] Strengthening evidence and surveillance to track GLP-1 use, access, outcomes, and inequities [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective] Countering misinformation through knowledge translation and health education initiatives [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective] The author writes that long-term effectiveness of GLP-1 drugs in everyday use remains uncertain, including whether changes are sustained and what happens after stopping treatment [Source: cpha.ca/glp-1-agonists-and-obesity-public-health-perspective]

I reached out to Prashant Yadav at the Council on Foreign Relations, who is one of the foremost authorities on global drug manufacturing